Publications of Udo Reichl
All genres
Talk (253)
401.
Talk
Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. 5th Workshop on Virus Dynamics, virtual (2021)
402.
Talk
Evolution and selection of influenza a virus defective interfering particles in a semi-continuous production system for the use as antiviral. The seventh ESWI Influenza Conference, Virtual Meeting (2020)
403.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Plenarsitzung der Sächischen Akademie der Wissenschaften zu Leipzig, Leipzig, Germany (2020)
404.
Talk
Multiscale model of DIP replication and its effects on influenza A virus infection in animal cell culture. Society for Mathematical Biology 2020 Annual Meeting, Virtual Meeting (2020)
405.
Talk
System diagnostics of the human gut microbiome using metaproteome analysis of fecal samples. Deutscher Kongress für Laboratoriumsmedizin, Magdeburg, Germany (2019)
406.
Talk
Identification of process parameters shaping microbial communities in biogas plants using large scale metaproteome analysis. Annual Conference of the Association for General and Applied Microbiology (VAAM), Mainz, Germany (2019)
407.
Talk
Biological conversion of CO2 from a biogas plant to CH4. Young Professionals Conference on Process Engineering (YCOPE 2019), Magdeburg (2019)
408.
Talk
A novel type of defective interfering particle for antiviral therapy. 26th ESACT Meeting, Copenhagen, Denmark (2019)
409.
Talk
Production of defective interfering particles of influenza A virus in continuously cultured bioreactors at two residence times - insights from within-host virus dynamics. 4th Workshop on Viral Dynamics, Paris, France (2019)
410.
Talk
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. ECI Advancing Manufacture of Cell and Gene Therapies VI, Coronado, United States of America (2019)
411.
Talk
Moderne Methoden der Impfstoffherstellung. Wissenschaft im Rathaus, Magdeburg, Germany (2019)
412.
Talk
Cell Culture-based Viral Vaccines: Process Intensification and Monitoring. Cuba Symposium “Frontiers of Science”, Havanna, Cuba (2019)
413.
Talk
glyXbox CE: A powerful tool in the glycoanalytical toolbox - improving biologics development. GlycoBioTec 2019, Berlin, Germany (2019)
414.
Talk
Dynamics of influenza A virus defective interfering particle replication. DARPA PI-Meeting, Arlington, United States of America (2019)
415.
Talk
Dynamics of influenza A virus defective interfering particle replication. DARPA PI Meeting, New York, United States of America (2019)
416.
Talk
High Yield Viral Vaccine Production: Process Options and Monitoring. 9th ISBioTech Spring Meeting, Norfolk, USA (2019)
417.
Talk
Process Intensification in Viral Vaccine Manufacturing. International Symposium on Pharmaceutical Engineering Research – SPhERe, Braunschweig, Germany (2019)
418.
Talk
Multiscale model of DIP interference and production during influenza A virus infection in animal cell culture. 4th Workshop on Virus Dynamics, Paris, France (2019)
419.
Talk
A universal platform for continuous manufacturing of viral vaccines & gene therapy vectors. Workshop Bioverfahrenstechnik, Leuna, Germany (2019)
420.
Talk
Mathematical modeling as a tool to improve influenza vaccine production processes. FOSBE 2018, Chicago, Illinois, USA (2018)